Summa Health System – FDA 483, Mar 21, 2023
An FDA inspection of Summa Health System, a hospital blood bank, identified significant deviations from written standard operating procedures for blood and blood component processing and distribution. The firm failed to ensure physicians signed emergency release forms for uncrossmatched blood and did not consistently follow protocols for monitoring vital signs during transfusions or stopping transfusions when reactions were suspected. These issues indicate a lack of adherence to established procedures, which could impact patient safety.
- Person
ID · 4e2dd2aa-162c-4f9e-a255-0a94fa033fc6
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.